Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash to Debt 6.89
PHMD's Cash to Debt is ranked higher than
59% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. PHMD: 6.89 )
Ranked among companies with meaningful Cash to Debt only.
PHMD' s 10-Year Cash to Debt Range
Min: 0.08  Med: 1.98 Max: N/A
Current: 6.89
Equity to Asset 0.65
PHMD's Equity to Asset is ranked higher than
51% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. PHMD: 0.65 )
Ranked among companies with meaningful Equity to Asset only.
PHMD' s 10-Year Equity to Asset Range
Min: 0.22  Med: 0.73 Max: 0.91
Current: 0.65
0.22
0.91
F-Score: 4
Z-Score: -0.75
M-Score: -11.23
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -22.43
PHMD's Operating margin (%) is ranked lower than
68% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. PHMD: -22.43 )
Ranked among companies with meaningful Operating margin (%) only.
PHMD' s 10-Year Operating margin (%) Range
Min: -7398.99  Med: -27.41 Max: 25.93
Current: -22.43
-7398.99
25.93
Net-margin (%) -107.50
PHMD's Net-margin (%) is ranked lower than
78% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.65 vs. PHMD: -107.50 )
Ranked among companies with meaningful Net-margin (%) only.
PHMD' s 10-Year Net-margin (%) Range
Min: -10020.2  Med: -32.33 Max: 102.49
Current: -107.5
-10020.2
102.49
ROE (%) -141.57
PHMD's ROE (%) is ranked lower than
93% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. PHMD: -141.57 )
Ranked among companies with meaningful ROE (%) only.
PHMD' s 10-Year ROE (%) Range
Min: -278.85  Med: -36.32 Max: 55.77
Current: -141.57
-278.85
55.77
ROA (%) -62.48
PHMD's ROA (%) is ranked lower than
82% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: 0.05 vs. PHMD: -62.48 )
Ranked among companies with meaningful ROA (%) only.
PHMD' s 10-Year ROA (%) Range
Min: -128.97  Med: -21.84 Max: 22.6
Current: -62.48
-128.97
22.6
ROC (Joel Greenblatt) (%) -51.54
PHMD's ROC (Joel Greenblatt) (%) is ranked lower than
62% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 3.52 vs. PHMD: -51.54 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PHMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -10543.79  Med: -63.87 Max: 163.98
Current: -51.54
-10543.79
163.98
Revenue Growth (3Y)(%) -8.80
PHMD's Revenue Growth (3Y)(%) is ranked lower than
78% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. PHMD: -8.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PHMD' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: -1.80 Max: 140.9
Current: -8.8
0
140.9
EBITDA Growth (3Y)(%) 60.90
PHMD's EBITDA Growth (3Y)(%) is ranked higher than
95% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. PHMD: 60.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
PHMD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -23.60 Max: 65.6
Current: 60.9
0
65.6
EPS Growth (3Y)(%) 278.40
PHMD's EPS Growth (3Y)(%) is ranked higher than
97% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. PHMD: 278.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
PHMD' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: -6.70 Max: 278.4
Current: 278.4
0
278.4
» PHMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

PHMD Guru Trades in Q3 2014

Jim Simons 44,900 sh (New)
Richard Snow Sold Out
Chuck Royce Sold Out
Mario Gabelli Sold Out
» More
Q4 2014

PHMD Guru Trades in Q4 2014

Jim Simons 364,200 sh (+711.14%)
» More
Q1 2015

PHMD Guru Trades in Q1 2015

HOTCHKIS & WILEY 17,067 sh (New)
Jim Simons 561,000 sh (+54.04%)
» More
Q2 2015

PHMD Guru Trades in Q2 2015

Jim Simons 638,600 sh (+13.83%)
HOTCHKIS & WILEY 17,067 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with PHMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 35.71
PHMD's Forward P/E is ranked lower than
77% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 23.31 vs. PHMD: 35.71 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 0.40
PHMD's P/B is ranked higher than
98% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 3.01 vs. PHMD: 0.40 )
Ranked among companies with meaningful P/B only.
PHMD' s 10-Year P/B Range
Min: 0.23  Med: 1.70 Max: 7.39
Current: 0.4
0.23
7.39
P/S 0.12
PHMD's P/S is ranked higher than
99% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. PHMD: 0.12 )
Ranked among companies with meaningful P/S only.
PHMD' s 10-Year P/S Range
Min: 0.12  Med: 1.30 Max: 6.55
Current: 0.12
0.12
6.55
Current Ratio 1.54
PHMD's Current Ratio is ranked lower than
76% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 2.44 vs. PHMD: 1.54 )
Ranked among companies with meaningful Current Ratio only.
PHMD' s 10-Year Current Ratio Range
Min: 0.78  Med: 2.22 Max: 9.54
Current: 1.54
0.78
9.54
Quick Ratio 0.88
PHMD's Quick Ratio is ranked lower than
81% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. PHMD: 0.88 )
Ranked among companies with meaningful Quick Ratio only.
PHMD' s 10-Year Quick Ratio Range
Min: 0.5  Med: 1.51 Max: 8.92
Current: 0.88
0.5
8.92
Days Inventory 326.35
PHMD's Days Inventory is ranked lower than
87% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 129.48 vs. PHMD: 326.35 )
Ranked among companies with meaningful Days Inventory only.
PHMD' s 10-Year Days Inventory Range
Min: 136.89  Med: 164.87 Max: 53381.25
Current: 326.35
136.89
53381.25
Days Sales Outstanding 35.22
PHMD's Days Sales Outstanding is ranked higher than
92% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 69.92 vs. PHMD: 35.22 )
Ranked among companies with meaningful Days Sales Outstanding only.
PHMD' s 10-Year Days Sales Outstanding Range
Min: 17.07  Med: 54.98 Max: 648.89
Current: 35.22
17.07
648.89

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 1.49
PHMD's Price/Net Current Asset Value is ranked higher than
96% of the 207 Companies
in the Global Medical Devices industry.

( Industry Median: 6.33 vs. PHMD: 1.49 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
PHMD' s 10-Year Price/Net Current Asset Value Range
Min: 2.57  Med: 9.46 Max: 22.82
Current: 1.49
2.57
22.82
Price/Tangible Book 1.27
PHMD's Price/Tangible Book is ranked higher than
90% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 4.01 vs. PHMD: 1.27 )
Ranked among companies with meaningful Price/Tangible Book only.
PHMD' s 10-Year Price/Tangible Book Range
Min: 1.68  Med: 4.83 Max: 30.6
Current: 1.27
1.68
30.6
Price/Projected FCF 0.16
PHMD's Price/Projected FCF is ranked higher than
99% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. PHMD: 0.16 )
Ranked among companies with meaningful Price/Projected FCF only.
PHMD' s 10-Year Price/Projected FCF Range
Min: 0.28  Med: 1.65 Max: 27
Current: 0.16
0.28
27
Price/Median PS Value 0.11
PHMD's Price/Median PS Value is ranked higher than
98% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. PHMD: 0.11 )
Ranked among companies with meaningful Price/Median PS Value only.
PHMD' s 10-Year Price/Median PS Value Range
Min: 0.15  Med: 1.39 Max: 330.07
Current: 0.11
0.15
330.07
Earnings Yield (Greenblatt) (%) -161.93
PHMD's Earnings Yield (Greenblatt) (%) is ranked lower than
98% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. PHMD: -161.93 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
PHMD' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -161.93  Med: 10.50 Max: 36.3
Current: -161.93
-161.93
36.3

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 243 249 269
EPS($) -0.70 -0.75 -0.55
EPS without NRI($) -0.70 -0.75 -0.55

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:PHMD.Israel, LA9A.Germany,
PhotoMedex Inc was originally formed in Delaware in 1980 and re-incorporated in Nevada on December 30, 2010. The Company is a skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. It provides proprietary products and services that address skin diseases and conditions including psoriasis, vitiligo, acne and photo damage. The physician market provides the platform to expand its skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. Its professional product line also offers for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas. It is also engaged in the development, manufacture and sale of surgical products, including proprietary free-beam and Contact Laser Systems for surgery. The Company operates in three business segments; Consumer segment, Physician Recurring segment and Professional segment. It emphasizes the development of physician-endorsed skin care products based on science. It has added a range of home-use devices under the no!no! brand, for various indications including hair removal, acne treatment, skin rejuvenation, and lower back pain. Its no!no! hair removal products are built upon its proprietary heat-based Thermicon brand technology to address consumer concerns over perceived limitations of existing hair removal products, including safety and pain, and to overcome inherent limitations of light-based hair removal solutions. The Company competes with small, closely held, specialized aesthetic device companies, such as Dezac Group, Home Skinovations Ltd., TRIA Beauty, Inc. and LumaTherm Inc, and several public companies, such as Syneron Medical Ltd, Cynosure Inc., and Valeant Pharmaceuticals, Inc. The Company's products and research and development activities are regulated by numerous governmental authorities, principally the FDA and corresponding state and foreign regulatory agencies.
» More Articles for PHMD

Headlines

Articles On GuruFocus.com
Weekly 3-Year Low Highlights: GES, QLGC, NPK, PHMD, FHCO Aug 31 2014 
4 Attractive Small-Cap Growth + Value Stocks You Have Never Heard Of Apr 16 2014 
Weekly CEO Sells Highlight: Tiffany & Co, Coleman Cable Inc, PhotoMedex Inc, Imax Corporation Jun 23 2013 
comment on PHMD Apr 16 2013 
comment on PHMD Apr 16 2013 
Is Photomedex Poised for a Short Squeeze? Apr 16 2013 
Weekly CEO Sells Highlight: Starbucks Corporation, Applied Materials Inc, PhotoMedex Inc, Gap Inc. Mar 10 2013 
Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD Jan 27 2013 
Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS Jan 21 2013 
PhotoMedex Inc. Reports Operating Results (10-Q) Aug 16 2010 

More From Other Websites
PHOTOMEDEX INC Financials Aug 21 2015
PHOTOMEDEX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 20 2015
PhotoMedex Announces No!No!™ Hair Breaks Record on Uk Home Shopping Television with the Fastest... Aug 20 2015
PhotoMedex Announces No!No!™ Hair Breaks Record on Uk Home Shopping Television with the Fastest... Aug 20 2015
PHOTOMEDEX INC Files SEC form 8-K, Other Events Aug 17 2015
10-Q for PhotoMedex, Inc. Aug 12 2015
PHOTOMEDEX INC Files SEC form 10-Q, Quarterly Report Aug 10 2015
PHOTOMEDEX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 10 2015
PhotoMedex Reports Second Quarter Financial Results Aug 10 2015
Exclusive: N.Y. medical device firm moving to Montco Jul 15 2015
PHOTOMEDEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Jun 26 2015
Montco skin care company sells laser treatment business for $42.5M Jun 23 2015
PhotoMedex (PHMD) Stock Gaining on Brands Sale Jun 23 2015
How MELA Plans to Buy XTRAC and VTRAC From PhotoMedex Jun 23 2015
PHOTOMEDEX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 23 2015
PhotoMedex Reports Strong no!no!™ Sales During Recent Home Shopping Events, Exceeding Unit Sales... Jun 23 2015
PhotoMedex Sells XTRAC® Business to MELA Sciences for $42.5 Million, Pays off All Outstanding Debt Jun 23 2015
PHOTOMEDEX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 11 2015
PhotoMedex Reports First Quarter Financial Results May 11 2015
5 Stocks Ready for Breakouts Apr 17 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK